lycorine has been researched along with Cancer of Cervix in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jang, X; Ma, Y; Shang, H; Shi, L | 1 |
| Fan, X; Li, Y; Li, Z; Liu, G; Liu, X; Zhou, Q | 1 |
2 other study(ies) available for lycorine and Cancer of Cervix
| Article | Year |
|---|---|
Lycorine inhibits cell proliferation and induced oxidative stress-mediated apoptosis via regulation of the JAK/STAT3 signaling pathway in HT-3 cells.
Topics: Acetylcysteine; Amaryllidaceae Alkaloids; Antineoplastic Agents; Antioxidants; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Humans; Janus Kinase 1; Membrane Potential, Mitochondrial; Oxidative Stress; Phenanthridines; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Signal Transduction; STAT3 Transcription Factor; Uterine Cervical Neoplasms | 2021 |
Lycorine upregulates the expression of RMB10, promotes apoptosis and inhibits the proliferation and migration of cervical cancer cells.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Mice; Phenanthridines; RNA-Binding Proteins; Uterine Cervical Neoplasms | 2022 |